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Abstract
Background: Formation of precise neuronal connections requires proper axon guidance. Microtubules (MTs) of the
growth cone provide a critical driving force during navigation of the growing ends of axons. Pioneer MTs and their
plus-end tracking proteins (+TIPs) are thought to play integrative roles during this navigation. TACC3 is a + TIP that
we have previously implicated in regulating MT dynamics within axons. However, the role of TACC3 in axon guidance
has not been previously explored.
Results: Here, we show that TACC3 is required to promote persistent axon outgrowth and prevent spontaneous axon
retractions in embryonic Xenopus laevis neurons. We also show that overexpressing TACC3 can counteract the
depolymerizing effect of low doses of nocodazole, and that TACC3 interacts with MT polymerase XMAP215 to
promote axon outgrowth. Moreover, we demonstrate that manipulation of TACC3 levels interferes with the
growth cone response to the axon guidance cue Slit2 ex vivo, and that ablation of TACC3 causes pathfinding
defects in axons of developing spinal neurons in vivo.
Conclusion: Together, our results suggest that by mediating MT dynamics, the + TIP TACC3 is involved in
axon outgrowth and pathfinding decisions of neurons during embryonic development.
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Background
Plus-end tracking proteins (+TIPs) selectively bind to
the dynamic plus-ends of microtubules (MTs), which ex-
tend into the distal part of the axon and growth cone
[1]. This enables + TIPs to come into close contact with
the cell cortex, where guidance cue receptors reside.
These receptors transduce asymmetrically-distributed
guidance signals down to intracellular effectors, which
then regulate MT dynamics in a spatially-restricted
manner that likely plays a key role in growth cone turn-
ing events [2, 3]. Thus, +TIPs deserve attention for their
potential function in regulating MT dynamics during
axon guidance. One of the first + TIPs to be discovered
for its role in axon guidance was CLASP [4]. Genetic
studies in Drosophila demonstrated that CLASP is a
downstream target of Abelson tyrosine kinase (Abl) in
the Slit/Robo guidance pathway during central nervous
system midline crossing [4]. Moreover, the + TIP and
MT polymerase, msps (fly ortholog of XMAP215/ch-
TOG) interacts with CLASP antagonistically during
this guidance decision in an Abl-dependent manner
[5]. In addition to its role in Drosophila, XMAP215
has been implicated in promoting axon outgrowth in
vertebrates [6]. We have recently shown that the
XMAP215-interactor, TACC3, is also a + TIP that reg-
ulates MT dynamics in vertebrate growth cones and
is essential for normal axonal outgrowth [7]. However,
how TACC3 specifically affects axon outgrowth and
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whether TACC3 plays a role during axon guidance re-
main to be explored.
In this study, we examine the role of TACC3 in axon
outgrowth and pathfinding in vivo within the developing
nervous system of Xenopus laevis which is a great model
for studying cytoskeletal dynamics during axon out-
growth and guidance [8, 9]. Using time-lapse live im-
aging, we demonstrate that TACC3 is required for
persistent axon outgrowth in Xenopus laevis, and that
both the N- and C- terminal conserved domains of
TACC3 are necessary for enhanced axon outgrowth.
Moreover, TACC3-overexpressing growth cones can
mitigate the reductive impacts of the MT-depolymerizing
agent, Nocodazole, on MT dynamics parameters. We also
show that TACC3 and XMAP215 can display a synergistic
effect and promote axon outgrowth ex vivo. Finally, exam-
ination of whole mount Xenopus spinal cords shows de-
fects in axon guidance in motor neurons when TACC3
levels are depleted, and manipulation of TACC3 levels im-
pacts the growth cone response to the repellent guidance
cue Slit2 in cultured Xenopus spinal neurons. Together,
these investigations provide new insights into the mechan-
ism by which TACC3 functions either alone or in combin-
ation with other + TIPs, such as XMAP215, to regulate
MT dynamics during axon outgrowth and guidance.
Methods
Xenopus embryonic explants
Egg collection and culturing of Xenopus embryonic ex-
plants (from embryos of either sex) were performed as
described [7, 10]. All experiments were approved by the
Boston College Institutional Animal Care and Use
Committee and were performed according to national
regulatory standards.
Constructs and RNA
Capped mRNA constructs were transcribed and purified
as previously described [6, 7] Constructs used were
GFP-TACC3 (TACC3 pET30a was gift from the Richter
lab, University of Massachusetts Medical School,
Worcester, MA), GFP-TACC3-ΔN, GFP-TACC3-ΔΔN,
GFP-TACC3-ΔTACC (see Fig. 1e for amino acid resi-
dues for full length and each deletion construct, based
on GenBank accession number NP-001081964.1) (all
TACC3 constructs were subcloned into pSC2+ vector),
GFP-MACF 43 (a gift from Hoogenraad Lab) in pCS2+,
XMAP215-GFP (a gift from the Hyman lab, Max Planck
Institute of Molecular Cell Biology and Genetics,
Dresden, Germany; [11]) subcloned into pT7TS.
Embryos either at the 2 cell or 4 cell stage received in-
jections 4 times total in 0.1× MMR containing 5% Ficoll
with the following total mRNA amount per embryo;
100 pg of GFP-MACF43 as a control for TACC3 or
XMAP215 overexpression, 2000 pg of GFP-TACC3
full-length and deletion constructs (deletion con-
structs are expressed in wildtype embryos), 3000 pg
of XMAP215-GFP. For double overexpression studies,
1000 pg of TACC3 and XMAP215 were injected in total.
Morpholinos
Morpholinos (MOs) were previously described and vali-
dated [6, 7]. In knockdown (KD) experiments, TACC3
and control MOs were injected at 80 ng/embryo. For
TACC3 and XMAP215 double KD analysis, 20 ng/em-
bryo for TACC3 and control MOs and 2 ng/embryo for
XMAP215 MO were injected. In rescue experiments,
MO (amounts used as in KD, which is 80 ng/embryo)
was injected with mRNA (same amount as in OE which
is 2000 pg/embryo for GFP-TACC3 and 3000 pg/embryo
for XMAP215-GFP) in the same injection solution. The
efficacy of MOs has been previously assessed by
Western blot of 35–36 stage embryos, as described [6, 7].
Whole-mount immunohistochemistry
Two-day-old embryos were fixed, as described [6]. Pri-
mary antibody (diluted in blocking buffer made up by
1% DMSO, 1% Triton, 1% BSA, in PBS) to acetylated
tubulin (1:1000, monoclonal, clone 6-11B-1, Sigma, St.
Louis, MO, USA) and goat anti-mouse Alexa-Fluor 568
conjugate secondary antibody (1:1000, polyclonal, A-
1100, Life Technologies) were used. For imaging, the
spinal cord was exposed by peeling off skin, and somites
were kept intact. Embryos were transferred in a drop of
benzoate:benzyl alcohol (BB:BA) to the imaging chamber
(made by placing Gene Frame, sticky on both sides, onto
a microscope slide). After the tissue was cleared, it was
covered with a 1.5× coverslip. Image acquisition and
quantitation of fixed and labeled explants were described
previously [6]. TACC3 KD-induced change is scored
based on the percentage of embryos with disorganized
axons in each condition.
Immunocytochemistry
Embryonic explant cultures were fixed and labelled [12]
with primary antibodies (1:1000 diluted in blocking buf-
fer made up by 1% non-fat dry milk in calcium and mag-
nesium free PBS) to tyrosinated tubulin (rat monoclonal,
ab6160, Abcam) and de-tyrosinated tubulin (rabbit poly-
clonal, AB3201, Millipore), and with the secondary anti-
bodies goat anti-rat Alexa Fluor 568 (1:1000, ab175476,
Abcam) and goat anti-rabbit Alexa Fluor 488 (1:1000,
A-11008, Life Technologies), respectively.
Growth cone response assay
Recombinant mouse Slit2 protein (R&D Systems)
(400 ng/ml) was administered to cultured neural tube
explants derived from stage 28 Xenopus embryos in
400 μl culture media supplemented with 1% Penicillin/
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Streptomycin and 0.1% BSA. A perfusion chamber was
set up to exchange media with Slit2-containing culture
media. Time-lapse images of growth cones were ac-
quired for 10 min with 30 s intervals before and imme-
diately after Slit2 addition for 30 min with 30 s intervals,
using a Zeiss Axio Observer inverted motorized micro-
scope with a Zeiss 20×/0.8 Plan Apo phase objective.
Frame to frame axon growth was tracked manually and
retraction or growth cone collapse events were recorded
over a movie. Ratio of the number of retracting frames
over total frames for each axon was scored. Images given
in the figures show the image of growth cone right
before adding Slit2 and the image of the growth cone
at collapse.
Nocodazole application
Nocodazole to final concentration of 50 pM was admin-
istered in 400 μl culture media. Concentration of
Nocodazole was determined after series of titrations and
50 pM was found to be the optimum to keep the MTs
intact in order to perform MT dynamics analyses. Time-
lapse images of growth cones were acquired for 1 min
with 2 s intervals before and 5 min after Nocodazole ad-
ministration, using a Yokogawa CSU-X1M 5000 spinning
disk confocal on a Zeiss inverted motorized microscope
with a Zeiss 63× Plan Apo 1.4 NA and a Hamamatsu
ORCA R2 CCD camera. MT dynamics were assessed, as
described [7].
PlusTipTracker software analysis
MT dynamics were analyzed from GFP-MACF43 movies
using plusTipTracker [10, 13]. Imaging conditions and
tracking parameters were previously validated and same
parameters were used: maximum gap length is 8 frames;
minimum track length is 3 frames; search radius range
5–12 pixels; maximum forward angle, 50°, maximum
backward angle, 10°; maximum shrinkage factor, 0.8;
fluctuation radius, 2.5 pixels; time interval, 2 s. MT
Fig. 1 TACC3 promotes axon outgrowth velocity and prevents spontaneous axon retractions. a, Axon outgrowth velocity is significantly decreased in
TACC3-depleted axons by 27% (n = 56) and in TACC3 OE, to a lesser extent, by 11% (n = 106) compared to control (GFP only) conditions (n = 58). b,
Retraction rate increased 5 fold in TACC3 KD (n = 107) and decreased 0.6 fold in TACC3 OE (n = 155) in comparison to their corresponding non injected
(n = 95) and GFP injected (n = 180) controls respectively. c, d, MT growth velocity (DMSO, n = 9, KHS-101, n = 9) (c) and axon outgrowth length (DMSO,
n = 8, KHS-101, n = 12) (d) are significantly reduced by 28 and 26% respectively after acute depletion of TACC3 by the inhibitor KHS101. e, Schematic
representation of GFP-tagged TACC3 full-length and deletion constructs, along with plus-end tracking ability (denoted by “+”) and impact on axon
outgrowth length. f, Quantification of axon outgrowth length in cultured neural explants of GFP injected control (n = 997), full-length GFP-TACC3
(1-931aa) (n = 787), GFP-TACC3-ΔN (133–931) (n = 613), GFP-TACC3- ΔΔN (363–931) (n = 563) and GFP-ΔTACC domain (1-635aa) (n = 764). *p < 0.05,
**p < 0.01, ***p < 0.001. ns not significant. n = axon/growth cone number
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growth lifetime is the measure of persistent outgrowth
till MT undergoes catastrophe. MT growth length is the
total growth over a movie and MT growth velocity is the
average of each MT growth event. MT dynamics param-
eters were compiled from multiple individual experi-
ments and to avoid day-to-day fluctuations the final
complied data were normalized to the mean of the con-
trol data for each experiment.
Image acquisition and analysis
For axon outgrowth imaging, phase contrast images of
axons were collected on a Zeiss Axio Observer inverted
motorized microscope with a Zeiss 20×/0.5 Plan Apo
phase objective and analyzed using ImageJ [7]. Time-
lapse images for axon outgrowth velocity was collected
for 4 h with 20 min intervals and images were analyzed
using plusTipTracker QFSM plugin and velocity was
measured as the average of instantaneous velocity per
axon as described [6]. Axon retraction events were ana-
lyzed from the same data set used to assess axon growth
velocity. Frame to frame axon growth was tracked
manually and retraction events were recorded over a
movie. Ratio of the number of retracting frames over
total frames for each axon was scored.
Axon outgrowth and MT dynamics data were normal-
ized to controls, to account for day-to-day fluctuations
in room temperature. Image acquisition and quantitation
of fluorescence intensity of fixed and labeled explants
were described previously [7]. Experiments were per-
formed multiple times to ensure reproducibility. Graphs
were made in GraphPad Prism. Statistical differences
were determined using unpaired two tailed t-tests when
comparing two conditions and one-way analysis of vari-
ance with Tukey’s post-hoc analysis when multiple condi-
tions were compared.
Results
TACC3 promotes persistent axon outgrowth by preventing
spontaneous axon retractions
We previously showed that normal axonal outgrowth re-
quires TACC3 [7]. To gain further insight into the
mechanism by which TACC3 promotes axon outgrowth,
we examined the effect of TACC3 knockdown (KD) and
overexpression (OE) on dynamic axon outgrowth pa-
rameters. Time-lapse imaging demonstrated that TACC3
KD significantly reduced axon outgrowth velocity by
25% relative to control conditions (TACC3 KD, 0.74 ±
0.03, n = 46, versus control, 1.04 ± 0.03 n = 57, ***p <
0.0001, Fig. 1a). In addition to the reduced outgrowth
velocity, TACC3 reduction dramatically increased axon
retraction rates by 5-fold in comparison to control axons
(TACC3 KD, 5.27 ± 1.22, n = 107, versus control, 1.06 ±
0.35, n = 99, **p = 0.0015, Fig. 1b). Conversely, when
TACC3 levels were elevated, the frequency of axon
retraction rates was reduced significantly by 45% com-
pared to controls (TACC3 OE, 0.54 ± 0.12, n = 155, ver-
sus control, 0.99 ± 0.12, n = 180, *p = 0.01, Fig. 1b).
Although TACC3 OE led to increased axonal length
(Fig. 1f ), TACC3 OE actually reduced axon outgrowth
velocity by 14% (0.89 ± 0.32, n = 103, versus control,
1.04 ± 0.033, n = 57, *p < 0.0268, Fig. 1a), suggesting that
the increased axonal length may result from reduced
axon retraction rather than a change in outgrowth
velocity.
To further explore the TACC3 KD phenotype, we ex-
amined axon outgrowth of cultured neurons in which
TACC3 was acutely inhibited by the TACC3 specific in-
hibitor, KHS-101 [14]. Consistent with the effect seen in
TACC3 KD, KHS-101-induced acute inhibition of
TACC3 significantly reduced MT growth velocity by 28%
(15.09 ± 0.86 μm/min (before drug treatment); 10.84 ±
0.75 μm/min (after drug), **p < 0.0019, Fig. 1c). More-
over, acute inhibition led to an immediate retraction of
axon length by 26% compared to vehicle treated controls
(KHS-101, 0.71 ± 0.05, n = 12, versus DMSO, 0.96 ± 0.03,
n = 9, ***p = 0.0007, Fig. 1d).
In order to determine which domains of TACC3 are
involved in axon outgrowth, we tested various trunca-
tion mutants of TACC3. We found that, while full-
length TACC3 and ΔN (lacking conserved N-terminal
domain) significantly increased axon outgrowth by 30%
(1.30 ± 0.03, n = 787, ***p < 0.0001) and 18% (1.18 ± 0.31,
n = 613, ***p < 0.0001) respectively, expression of ΔTACC
(lacking the conserved TACC domain, which has been
shown to be required for centrosome localization and
interaction with the MT polymerase, XMAP215) caused a
significant reduction by 12% in axon length (0.87 ± 0.021,
n = 764, ***p = 0.0002) in comparison to wild-type neurons
(0.99 ± 0.02, n = 997) (Fig. 1f). On the other hand, the lar-
ger N-term deletion (lacking both the conserved
N-terminus and the putative SxIP-like motif that is known
to mediate EB1 interaction for other + TIPs) showed no
significant difference (1.04 ± 0.028, n = 563, p = 0.2012).
Additionally, none of the deletion constructs that pro-
moted axon outgrowth were as effective as full-length
TACC3 OE (Fig. 1f).
Together, our findings suggest that TACC3 is required
for proper axon outgrowth by opposing axonal retract-
ing forces. Additionally, full-length TACC3 is more effi-
cient in promoting axon outgrowth than its truncation
mutants, while expression of a version lacking the TACC
domain results in a mild dominant negative effect.
TACC3 antagonizes nocodazole-induced MT
depolymerization but does not affect MT lattice stability
Previously, we determined that TACC3 promotes effi-
cient MT polymerization by enhancing MT growth vel-
ocity within growth cones [7]. However, the mechanism
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by which TACC3 affects MT polymerization remains
to be elucidated. Thus, we sought to gain further
insight by assessing the impact of low doses of the
MT depolymerizing drug, nocodazole, after TACC3
manipulation.
We observed that a low dose of nocodazole led to re-
duction in several parameters of MT dynamics, and that
TACC3 OE could mitigate these effects. While control
growth cones exhibited a marked 20% decrease in MT
growth speed after treatment with 50 pM nocodazole
(before, 1.00 ± 0.04, n = 22, after treatment, 0.79 ± 0.03,
n = 22, ***p = 0.0001), TACC3 OE growth cones showed
reduction by only 12% (before, 1.08 ± 0.04, n = 21, after
nocodazole, 0.95 ± 0.03, n = 21, *p = 0.0316, Fig. 2a).
Similar trends were observed with MT growth lifetime,
in which control growth cones showed a 15% reduction
(before, 1.00 ± 0.03 s, n = 22, after nocodazole, 0.84 ±
0.03 s, n = 22,***p = 0.0008) versus only a 3% reduction
with TACC3 OE (before, 0.91 ± 0.03, n = 21, after noco-
dazole, 0.87 ± 0.03, n = 21, p = 0.4305, Fig. 2b), and for
MT growth length, there was a 35% reduction in con-
trols (before, 1.00 ± 0.05, n = 22, after nocodazole, 0.65 ±
0.03, n = 22, ***p < 0.0001) versus 14% in TACC3 OE
(before, 1.00 ± 0.04, n = 21, after nocodazole, 0.85 ± 0.04,
n = 21, *p = 0.02, Fig. 2c). These results suggest that
TACC3 can mitigate the nocodazole-induced reduc-
tion in MT growth dynamics parameters. This mitiga-
tion can be more clearly visualized when the
nocodazole-induced change is represented as the ratio
of after treatment/before treatment. Although the
relative reduction in MT growth speed when TACC3
is overexpressed is only slightly less compared to con-
trols and is not quite statistically significant (0.91 ±
0.06 n = 21 versus control 0.82 ± 0.04 n = 22, ns p =
0.2, Fig. 2a’), for other MT growth parameters,
TACC3 OE significantly dampens the nocodazole-
induced reduction in lifetime (0.99 ± 0.047 n = 21 ver-
sus control 0.86 ± 0.03 n = 22, *p = 0.03, Fig. 2b’) and
length (0.91 ± 0.08 n = 21 versus control 0.68 ± 0.04
n = 22, *p = 0.01, Fig. 2c’) compared to controls.
In addition to MT polymerization, MT stabilization is
considered to be an important parameter for axon out-
growth and growth cone turning events [12]. Hence, we
measured the fluorescence intensities of tyrosinated and
de-tyrosinated tubulin in the growth cone and assessed
dynamic and stable MT lattice profiles, in TACC3-
manipulated growth cones. We found that the ratio of
tyrosinated tubulin versus de-tyrosinated tubulin did not
statistically differ in TACC3 KD (0.87 ± 0.07, n = 37, p =
0.2394) nor in TACC3 OE (1.01 ± 0.11, n = 129, p =
0.9673) growth cones, with respect to control growth
cones (1.00 ± 0.09, n = 143, Fig. 2d-f ). This suggests that
TACC3 may not specifically regulate MT lattice stability
in growth cones.
TACC3 and XMAP215 interact to promote axon outgrowth
We previously found that the TACC3 interactor and MT
polymerase, XMAP215, also promotes axon outgrowth
[6], and that TACC3 and XMAP215 co-localize at the
extreme plus-end of MTs in growth cones in a co-
dependent manner [7]. However, the consequences of
their interaction on axon development have not been
elucidated. Therefore, we sought to test whether TACC3
and XMAP215 might cooperate synergistically to pro-
mote axon outgrowth by partially elevating or reducing
TACC3 and XMAP215 levels alone and in combination
with each other. While a very mild TACC3 KD (approxi-
mately 20–30% less) led to 10% reduction in axon out-
growth (204.7 ± 4.8 μm, n = 487, p = 0.3528) and partial
XMAP215 KD led to 13% reduction (185.6 ± 6.4 μm, n
= 312, *p = 0.0116), partial knockdown of both reduced
axon length significantly by 34% (140.6 ± 3.5 μm, n =
552, ***p < 0.0001) compared to control axons (213.6 ±
9.6 μm, n = 219, Fig. 3a). Conversely, overexpression of
both (double OE) increased axon length by 32.7% (237.7
± 5.4 μm, n = 654, ***p < 0.0001) while TACC3 OE alone
increased by 11% (198.9 ± 3.2, n = 1585, ***p < 0.0001)
and XMAP215 OE increased by 30.9% (234.5 ± 4.3 μm,
n = 1227, ***p < 0.0001) in comparison to controls (179.1
± 3.2 μm, n = 1288, Fig. 3b). Interestingly, while double
OE significantly increased axon length in comparison to
TACC3 OE alone (***p < 0.0001), it did not show a dif-
ference when compared to XMAP215 alone (p = 0.6421)
suggesting that there may be an upper threshold that is
reached with XMAP215 OE by itself.
We next asked whether overexpression of one + TIP
might rescue the reduced axon length in the absence of
the other. We observed that overexpressing XMAP215
in the stronger TACC3 KD background brought axon
outgrowth length to control levels (TACC3 KD +
XMAP215 OE, 149.4 ± 5.2 μm, n = 313, **p = 0.005, ver-
sus control, 148.8 ± 3.6 μm, n = 558, p = 0.9331) by in-
creasing the length 15% in comparison to TACC3 KD
(129.7 ± 4.477 μm, n = 289, **p = 0.0015, Fig. 3c). On the
other hand, overexpression of TACC3 in the XMAP215
KD background increased axon outgrowth length by
30% (XMAP215 KD + TACC3 OE, 262.2 ± 7.8 μm, n =
397, ***p < 0.0001) in comparison to XMAP215 KD
(201.3 ± 7.2 μm, n = 299); however, the rescue was not
complete when compared to control axons (Control,
304.9 ± 8.5 μm, n = 463, ***p = 0.003, Fig. 3d). These
findings suggest that TACC3 and XMAP215 cooperate
during axon outgrowth, with XMAP215 showing more
additive effects on TACC3-mediated axon outgrowth.
TACC3 affects axon guidance in vivo and ex vivo
The direction that the growth cone acquires during out-
growth is a result of local modulation of MT dynamics
in response to guidance signals [12, 15–17]. Thus, we
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wondered whether TACC3 regulation of MT dynamics
could play a role during axon guidance. We first exam-
ined motor neuron axon outgrowth from the spinal cord
in embryos at an early developmental stage (st 28), and
we discovered that reduction of TACC3 caused signifi-
cantly impaired outgrowth and severely disrupted
morphology in all embryos examined (Fig. 4a-c). To gain
greater insight into whether TACC3 manipulation causes
this disorganization under specific guidance signals, we
examined growth cone behavior in response to the
guidance molecule, Slit2, applied in culture media. Slit2
is a repellent guidance cue which has been previously
studied with other + TIPs, such as CLASP [4], and the
response of growth cones of different neuron types iso-
lated from Xenopus embryos at different stages has been
previously documented [18–20]. We monitored the
changes in growth cone behavior for 10 min prior and
for 30 min after addition of Slit2. Growth cones that
show persistent growth were picked to be analyzed for
their behavior after Slit2 addition. Growth cones that
Fig. 2 TACC3 antagonizes Nocodazole-induced MT depolymerization but does not affect MT stability. a-c, Quantification of the MT dynamics
shows significant reduction in MT growth speed (a), MT lifetime (b) and MT growth length (c) in control (n = 22) and TACC3 OE (n = 21) growth
cones in response to 50 pM Nocodazole before and 5 min after drug treatment. However, the effect of Nocodazole on TACC3 OE growth cones
is dampened compared to controls. a’-c’, Although not significant, reduction in MT growth speed (a’) is more prominent in control growth cones
compared to TACC3 OE growth cones while the reduction in both lifetime (b’) and length (c’) in control growth cones are significantly higher
than the TACC3 OE growth cones (d) Representative growth cone images of control, TACC3 KD and TACC3 OE, immunostained for tyrosinated
tubulin (red) and detyrosinated tubulin (green) to label dynamic versus stable MTs, respectively. e-f, Quantification of the fluorescence intensity of
imaging data in G, with TACC3 KD (n = 38) (e) and TACC3 OE (n = 129) (f) growth cones showing no significant changes in dynamic/stable MTs
compared to corresponding control growth cones (n = 37 and n =143, respectively). *p < 0.05, **p < 0.01, ***p < 0.001. ns not significant. n = growth
cone number. Scale bar, 2 μm
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had reduced lamellipodial area were considered as col-
lapsed. We found that TACC3 OE growth cones had sig-
nificantly fewer growth cone collapse and axon
retraction events (TACC3 OE, 21.28 ± 7.24 n = 76 versus
control, 54.72 ± 4.26 n = 44, *p = 0.0164) in response to
Slit2, when compared to wild type growth cones
(Fig. 4d-e). This suggests that overexpressing TACC3
can counteract Slit2-induced growth cone collapse.
Discussion
Dynamic spatial and temporal regulation of MTs within
the growth cone is considered to be of key importance
during axon outgrowth, guidance decisions and regener-
ation events [12, 15–17, 21, 22]. Accordingly, MT plus-
end tracking proteins (+TIPs) likely play a critical role
during axon guidance, as + TIPs dominate the dynamic
portion of MTs that reaches the growth cone periphery,
where guidance cue receptors reside [2]. However, few +
TIPs have been examined within the context of the em-
bryonic growth cone. We previously characterized a MT
plus-end tracking function for TACC3 and showed that
it can promote MT polymerization and is required for
proper axonal development [7]. Here, we sought to un-
cover new insights into the mechanism underlying
axonal regulation by TACC3.
First, we found that the shorter axons that result from
reduced levels of TACC3 were due to slower axon out-
growth velocity along with significantly increased retrac-
tion rate. Moreover, TACC3 overexpression leads to
longer axons, not because of fast axon outgrowth vel-
ocity (the outgrowth rate was actually slower than in
controls), but because of reduced axon retraction rate.
This suggests that TACC3-mediated MT dynamics may
be required for opposing the normally-occurring retrac-
tive forces within axons. Another possible explanation is
that the reduced axon outgrowth velocity and reduced
axonal retraction rates after TACC3 OE could be due to
stronger anchorage to the underlying substrate and ad-
hesion turnover. While there are some + TIPs that have
been implicated to mediate MT – focal adhesion inter-
actions [23], TACC3 has not yet been explored in focal
adhesion (or point contacts, in the case of growth cones)
regulation. However, since TACC3 has been identified as
an interactor of CLASP [24], and given that CLASP is
known to function during focal adhesion turnover [25],
future studies should examine whether TACC3 also
plays a role at focal adhesions/point contacts.
+TIPs modulate MT dynamic instability in various
ways; for example, XMAP215 promotes MT growth
by catalyzing addition of tubulin dimers [26], while
CLASP and APC rescue MT from catastrophe by in-
creasing MT stability [27–29]. Here, we showed that
TACC3 OE can dampen nocodazole-induced reduc-
tion in MT growth speed, length and lifetime. How-
ever, this was not achieved by increased MT lattice
stability, as immunofluorescence analysis of dynamic
versus stable MTs revealed that TACC3 has no ap-
parent impact on MT stability within the growth
cone. It is unclear how TACC3 is able to mitigate
the reduction in MT growth speed, length and life-
time as a result of nocodazole application. One pos-
sibility could be that TACC3 overexpression, which
enhances XMAP215 localization at MT plus ends [7],
may simply promote more efficient and processive
MT polymerization by XMAP215 to counteract the
nocodazole-induced effects.
Fig. 3 TACC3 and XMAP215 interacts to promote axon outgrowth.
a, b, Combinatorial reduction or elevation of TACC3 and XMAP215
levels reveals synergistics in axon outgrowth. Knocking down both
TACC3 and XMAP215 (n = 312) showed significant reduction in axon
length in comparison to control (n = 219), TACC3 KD (n = 487) and
XMAP21 KD alone (n = 312) (a). Overexpression of both (n = 654)
showed significant increase in axon length in comparison to control
(n = 1288) and TACC3 OE (n = 1585), while double overexpression
had no additive effect in comparison to XMAP215 OE (n = 1227) (b).
c, d, Reduced axon outgrowth in TACC3 KD (n = 289) (c) or XMAP215
KD (n = 299) (d) neurons is rescued by the overexpression of
XMAP215 (n = 313) or TACC3 (n = 397), respectively. *p < 0.05,
**p < 0.01, ***p < 0.001. ns not significant. n = axon number
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Individual + TIPs comprise a network of proteins at
MT plus-ends which can co-localize and function
together to modulate MT dynamics. We have previously
shown such cooperation between TACC3 and XMAP215
in growth cones, as we demonstrated that TACC3 and
XMAP215 co-localize at MT plus-ends in co-dependent
manner [7].
Here, we found that TACC3 and XMAP215 interact to
promote axon outgrowth (Fig. 3). Partially knocking
down both TACC3 and XMAP215 resulted in further
reduction in axon outgrowth length, which suggests a
synergistic interaction between the two proteins. How-
ever, overexpression of both + TIPs did not show further
increase in axon length in comparison to XMAP215 OE
alone. This might be due to an upper threshold that is
reached with overexpression of XMAP215 alone.
Conversely, rescue studies show that XMAP215 can fully
restore TACC3 KD-mediated reduced axon length to
control levels, whereas TACC3 OE fails to show the
same impact over XMAP215 KD. As XMAP215 is a
Fig. 4 TACC3 affects axon guidance in vivo and ex vivo. a, b, confocal images of laterally-viewed whole-mount Xenopus spinal cord fluorescently
labeled for acetylated tubulin, showing peripheral axon outgrowth in control (a) and TACC3 KD (b) embryos at 2 dpf. c, Quantitation of the embryos
with motor neuron guidance defects (n = 5 embryos). d, Representative neural tube growth cone images of control and TACC3 OE, before and after
addition of 400 ng/ml Slit2. e, Quantification of the percentage of the growth cone collapse events in control (n = 48) and TACC3 OE (n = 82) growth
cones show significant reduction in growth cone collapse in TACC3 overexpressing growth cones. f, Cartoon model for the role of TACC3 at MT plus
ends during axon outgrowth and guidance. Microtubule (blue) plus-ends decorated by TACC3 (green) promotes axon outgrowth, reduces axon
retraction, dampens nocodazole induced reduction in MT dynamics parameters, rescues XMAP215 KD induced axon length reduction and
opposes repellent guidance signals effect. *p < 0.05, **p < 0.01, ***p < 0.001. ns not significant. n = growth cone number. Scale bar, 50 μm and 5 μm
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processive MT polymerase, reduction in XMAP215
levels may exert more dramatic effect than the reduction
in the levels of TACC3, which may play more of an
accessory role. Considering that one study suggests that
every TACC3 molecule is thought to interact with two
molecules of XMAP215 [30], reduced levels of
XMAP215 could be a limiting factor. Even though
TACC3 OE functions to increase available XMAP215 at
MT plus-ends, the reduction in overall XMAP215 levels
may result in poor axon outgrowth. While knock down
approaches provide supporting evidence regarding the
combinatorial role of TACC3 and XMAP215 during
axon outgrowth, future studies should utilize mutations
that disrupt their interaction [30] in order to understand
the dependence of these two proteins on one another
during axon outgrowth.
In addition to their role in axon outgrowth, several +
TIPs have been implicated in participating in growth
cone steering decisions in response to extracellular cues.
The first of which is orbit/MAST, the fly ortholog of
mammalian CLASP, that has been identified to cooper-
ate with Abelson kinase (Abl) downstream of Slit/Robo
guidance pathway [4]. In a parallel genetic and prote-
omic screen in fruit flies, minispindles (msps), a fly
ortholog of Xenopus XMAP215, was identified to func-
tion antagonistically against CLASP and Abl during em-
bryonic central nervous system development [5], while
another genetic interaction study in flies identified dtacc
as an antagonist of CLASP [24], reminiscent of the inter-
action between CLASP and TACC partner, msps. Com-
bining these previous works with our findings on the
role of TACC3 in axon outgrowth led us to ask whether
TACC3 functions during axon guidance. As demon-
strated in Fig. 4a, our initial observations revealed that
reduction in TACC3 levels impairs the normal
organization of axons exiting the spinal cord in embryos
at st 28. Stimulation of cultured Xenopus retinal neurons
at stage 32 or beyond with bath-applied Slit2 has been
shown to cause growth cone collapse [19]. Additionally,
spinal neurons derived from st 28 Xenopus embryos
have been previously shown to be repelled by Slit2 [18].
Here, we found that Slit2-induced neural tube growth
cone collapse events can be reduced by 60% in TACC3
overexpressing growth cones in comparison to control,
suggesting an opposing role for TACC3 in Slit2-induced
growth cone collapse. Based on its role in MT
polymerization [7], its co-dependent localization at MT
plus ends with XMAP215 [7], and their interaction dur-
ing axon outgrowth (Fig. 3), we propose that TACC3 OE
will excessively occupy MT plus-ends, subsequently
driving increased recruitment of XMAP215, prompting
enhanced MT polymerization in all directions. This glo-
bal increase in MT polymerization would disturb local
MT modulation, which is the underlying mechanism for
growth cone steering events and it would result in an
aberrant, non-obedient growth cone advance (Fig. 4f ).
It remains to be determined whether these effects
are specific to Slit2 or if TACC3 could exert similar
opposing effects in response to other repellent signals,
and/or if TACC3 mediates attractive signals as well.
Finally, other TACC members, namely, TACC1 and
TACC2, have recently been characterized as + TIPs
that can promote MT polymerization in Xenopus em-
bryonic cells [31, 32]. Although their expression and
MT regulatory function show cell type-specificity, it
would be intriguing to study whether other members
of the TACC family also play a role in axon out-
growth and guidance decisions.
Conclusion
This study characterizes the mechanism by which
TACC3 regulates MT dynamics within the embryonic
neuronal growth cone and promotes axon outgrowth.
Using time-lapse imaging of Xenopus laevis embryonic
axons as they grow in culture, we demonstrated that
TACC3 promotes persistent axon outgrowth not by
accelerating axon growth velocity but by reducing spon-
taneous axon retraction events. Moreover, we demon-
strate that overexpressing TACC3 can mitigate the
reduction in MT dynamics parameters that occur
after Nocodazole application, suggesting that TACC3
may be promoting MT dynamics by dampening MT
depolymerization. Finally, our data suggests that the +
TIP TACC3 mediates axon guidance, as reduction in
TACC3 levels results in defects in the normal
organization of spinal neuron axons within the spinal
cord. Moreover, bath application of the Slit2 repellent
guidance molecule into cultured neural tube neurons
shows that TACC3 OE reduce the Slit2 induced
growth cone collapse events suggesting that TACC3
may involve in generation of response to guidance
signals during neuronal development.
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